Insider trading

Period: 120 months Stock: TRDA + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

215 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

215 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

215 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

215 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
215 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
215 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

215 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
9 Sep 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$205.61K 28,837 at 7.13
0.7%
Not planned
9 Sep 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$205.61K 28,837 at 7.13
0.7%
Not planned
8 Sep 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$1.43M 192,500 at 7.41
4.7%
Not planned
8 Sep 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$1.43M 192,500 at 7.41
4.7%
Not planned
4 Sep 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$273.74K 38,500 at 7.11
0.9%
Not planned
4 Sep 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$273.74K 38,500 at 7.11
0.9%
Not planned
3 Sep 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$231.33K 32,263 at 7.17
0.8%
Not planned
3 Sep 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$231.33K 32,263 at 7.17
0.8%
Not planned
2 Sep 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$180.69K 25,131 at 7.19
0.6%
Not planned
2 Sep 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$180.69K 25,131 at 7.19
0.6%
Not planned
1 Sep 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$205.36K 29,088 at 7.06
0.7%
Not planned
1 Sep 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$205.36K 29,088 at 7.06
0.7%
Not planned
31 Aug 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$309.37K 44,259 at 6.99
1.0%
Not planned
31 Aug 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$309.37K 44,259 at 6.99
1.0%
Not planned
28 Aug 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$26.17K 3,733 at 7.01
0.1%
Not planned
28 Aug 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$26.17K 3,733 at 7.01
0.1%
Not planned
27 Aug 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$280.24K 38,922 at 7.20
0.9%
Not planned
27 Aug 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$280.24K 38,922 at 7.20
0.9%
Not planned
26 Aug 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$102.86K 14,569 at 7.06
0.3%
Not planned
26 Aug 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$102.86K 14,569 at 7.06
0.3%
Not planned
25 Aug 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$199.98K 26,522 at 7.54
0.6%
Not planned
25 Aug 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$199.98K 26,522 at 7.54
0.6%
Not planned
24 Aug 2026
MPM BioVentures 2014, L.P. 10% owner · indirect
Sold at will
$158.71K 21,623 at 7.34
0.5%
Not planned
24 Aug 2026
MPM BIOVENTURES 2018, L.P. 10% owner · indirect
Sold at will
$158.71K 21,623 at 7.34
0.5%
Not planned
10 Aug 2026
PARMAR KUSH Director · indirect
Sold at will
$647.11K 92,444 at 7.00
3.3%
Not planned
7 Aug 2026
Sold at will
$358.37K 52,317 at 6.85
1.8%
Not planned
7 Aug 2026
PARMAR KUSH Director · indirect
Sold at will
$358.37K 52,317 at 6.85
1.8%
Not planned
6 Aug 2026
PARMAR KUSH Director · indirect
Sold at will
$73.46K 10,494 at 7.00
0.4%
Not planned
6 Aug 2026
Sold at will
$73.46K 10,494 at 7.00
0.4%
Not planned
31 Jul 2026
Sold at will
$11.77K 1,718 at 6.85
0.1%
Not planned
31 Jul 2026
PARMAR KUSH Director · indirect
Sold at will
$11.77K 1,718 at 6.85
0.1%
Not planned
30 Jul 2026
PARMAR KUSH Director · indirect
Sold at will
$795.26K 114,756 at 6.93
3.9%
Not planned
30 Jul 2026
Sold at will
$795.26K 114,756 at 6.93
3.9%
Not planned
20 May 2026
Zeiher Bernhardt G Director · indirect
Bought
$29.32K 5,000 at 5.86
opened
First buy on file
4 May 2026
Sethuraman Natarajan President, Research & Develop.
Sold on a plan
$398.81K 25,907 at 15.39
10.7%
Planned (10b5-1)
4 May 2026
Dowden Nathan J President & COO
Sold on a plan
$229.95K 15,000 at 15.33
7.0%
Planned (10b5-1)
1 Apr 2026
WENTWORTH KORY JAMES Chief Financial Officer
Sold on a plan
$32.38K 2,500 at 12.95
2.1%
Planned (10b5-1)
10 Mar 2026
Dowden Nathan J President & COO
Sold on a plan
$155.19K 11,894 at 13.05
5.7%
Planned (10b5-1)
10 Mar 2026
WENTWORTH KORY JAMES Chief Financial Officer
Sold on a plan
$148.22K 11,388 at 13.02
8.6%
Planned (10b5-1)
9 Mar 2026
WENTWORTH KORY JAMES Chief Financial Officer
Sold on a plan
$66.16K 5,089 at 13.00
3.7%
Planned (10b5-1)
9 Mar 2026
Dowden Nathan J President & COO
Sold on a plan
$40.58K 3,116 at 13.02
1.5%
Planned (10b5-1)
4 Mar 2026
WENTWORTH KORY JAMES Chief Financial Officer
Sold on a plan
$97.89K 7,988 at 12.25
5.5%
Planned (10b5-1)
21 Nov 2025
WENTWORTH KORY JAMES Chief Financial Officer
Sold on a plan
$88.93K 8,910 at 9.98
7.5%
Planned (10b5-1)
20 Nov 2025
BAKER BROS. ADVISORS LP 10% owner · indirect
Bought 4×
$261.85K 28,867 at 9.07
0.6%
14 Nov 2025
PARMAR KUSH Director · indirect
Sold at will
$1.76M 200,000 at 8.80
6.3%
Not planned
14 Nov 2025
Sold at will
$1.76M 200,000 at 8.80
6.3%
Not planned
12 Nov 2025
BAKER BROS. ADVISORS LP 10% owner · indirect
Bought 4×
$781.64K 100,736 at 7.76
2.2%
Largest buy in 3 yrs
11 Nov 2025
BAKER BROS. ADVISORS LP 10% owner · indirect
Bought 4×
$348.19K 46,434 at 7.50
1.0%
Largest buy in 3 yrs
10 Nov 2025
BAKER BROS. ADVISORS LP 10% owner · indirect
Bought 4×
$222.76K 30,874 at 7.21
0.7%
First buy in 3+ yrs
9 Jul 2025
PARMAR KUSH Director · indirect
Sold at will 2×
$202.55K 27,000 at 7.50
2.4%
Not planned
Showing 1–50 of 215. Page 1 of 5 Older →